Identification of hematopoietic-specific regulatory elements from the CD45 gene and use for lentiviral tracking of transplanted cells.
Identification of hematopoietic-specific regulatory elements from the CD45 gene and use for lentiviral tracking of transplanted cells.
复制标题
DOI:
10.1016/j.exphem.2014.05.005
复制
发表时间:
2014-09
影响因子:
2.6
通讯作者:
Levasseur, Dana N.
中科院分区:
文献类型:
--
作者:
Duong, Khanh L.;Das, Satyabrata;Yu, Shuyang;Barr, Jennifer Y.;Jena, Snehalata;Kim, Eunmi;Zavazava, Nicolas;Colgan, John D.;Xue, Hai-Hui;Levasseur, Dana N.
The development of a hematopoietic reporter is crucial for determining the fate of lineages derived from cell-based therapies. A marking system will enable safer embryonic stem (ES) and induced pluripotent stem (iPS) cell-based derivation of blood lineages, and facilitate the development of efficient cellular reprogramming strategies based on direct fibroblast conversion. Here we report that the protein tyrosine phosphatase CD45 is an ideal candidate gene on which to base a hematopoietic reporter. CD45 regulatory elements were discovered by analyzing transcription factor chromatin occupancy (ChIP-seq) and promoter nuclease sensitivity (DNase-seq) to identify minimally sufficient sequences required for expression. After cloning the CD45 regulatory elements into an attenuated lentiviral backbone, we found that two transcriptional initiation regions were essential for high-level expression. Expressing CD45 promoters containing these regions and tethered to GFP in a primary B cell differentiation assay and a transplantation model resulted in high levels of GFP in lymphoid, myeloid and nucleated erythroid cells in mouse and human blood cell lineages. Moreover, high GFP levels remained five months following secondary transplantation, indicating persistence of the reporter. No CD45 driven GFP expression is observed following fibroblast or ES cell transduction. The GFP reporter is seen only after ES cells differentiate into hematopoietic cell progenitors and lineages, suggesting that this hematopoietic reporter system could be useful in validating potential autologous blood cell therapies.
登录
查看更多内容
DOI:
10.1186/1745-7580-4-5
发表时间:
2008-04-29
期刊:
Immunome research
影响因子:
--
作者:
Lattin JE;Schroder K;Su AI;Walker JR;Zhang J;Wiltshire T;Saijo K;Glass CK;Hume DA;Kellie S;Sweet MJ
通讯作者:
Sweet MJ
DOI:
10.1084/jem.20110447
发表时间:
2011-11-21
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Kataoka K;Sato T;Yoshimi A;Goyama S;Tsuruta T;Kobayashi H;Shimabe M;Arai S;Nakagawa M;Imai Y;Kumano K;Kumagai K;Kubota N;Kadowaki T;Kurokawa M
通讯作者:
Kurokawa M
影响因子:
20.3
作者:
Chan, Kun-Ming;Bonde, Sabrina;Zavazava, Nicholas
通讯作者:
Zavazava, Nicholas
影响因子:
23.9
作者:
Rossi, Lara;Lin, Kuanyin K.;Boles, Nathan C.;Yang, Liubin;King, Katherine Y.;Jeong, Mira;Mayle, Allison;Goodell, Margaret A.
通讯作者:
Goodell, Margaret A.
影响因子:
64.8
作者:
Robinton, Daisy A.;Daley, George Q.
通讯作者:
Daley, George Q.